BHVN

Conviction 31HealthcareScan · Thu, Sep 24, 2026

Biohaven Ltd. (BHVN) closed at $13.18 (-3.62%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 45, RS Rating 51, -27.3% from its 52-week high, +21.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

BHVN$13.18-3.62%

ResistanceSupportVol 14

Vol MA14 3.63M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Biohaven Ltd.PHARMACEUTICAL PREPARATIONSwww.biohaven.com ↗

Price13.18

Change-3.62%

Gap-0.40%

Rel volume0.96×

Avg volume3.47M

Avg $ vol49.19M

SMA 2014.27

SMA 5014.31

SMA 20011.98

Price vs 50-7.92%

Price vs 200+10.01%

MA stackmixed

50/200 cross—

Supertrenddown · 15.38

RSI (14)45

MACD hist-0.03

MACD crossbear · 0d

Stoch %K / %D32 / 45

ADX (14)17

+DI / −DI21 / 25

RSI divergence—

MACD divergence—

ATR %8.35%

ADR %7.37%

52w high18.11

52w low7.79

From 52w high-27.25%

Above 52w low+69.13%

New 52w highNo

SqueezeOff

Bollinger width36.39%

%B0.29

Donchian pos24.32%

Donchian high17.05

Donchian low11.93

AVWAP (52w high)11.62

vs AVWAP high+13.41%

AVWAP (52w low)11.81

vs AVWAP low+11.60%

OBV trendDown

Chaikin MF (20)-0.16

Today vs 20d0.96×

Avg vol (14d)3.63M

Avg vol (20d)3.47M

Avg $ vol (20d)49.19M

Market cap1.99B

RS Rating51 / 99

RS 3m (vs SPY)-18.60%

RS 6m (vs SPY)+36.20%

RS line new highNo

Trend template5/8

Technical rank60.2

1 week-5.15%

1 month-8.38%

3 months-14.11%

6 months+53.02%

1 year-6.96%

YTD+21.54%

P/E-2.69

P/B162.82

P/S—

P/FCF-3.26

EPS-6.86

Div yield—

ROE—

ROA-199.28%

Debt/Eq—

Current4.73

EV/EBITDA-2.38

Gross margin—

Net margin—

Rev growth—

EPS growth12.71%

Price target19.67

Target upside49.30%

Analyst ratingBuy

Institutional108.75%

Ent. value1.75B

Revenue—

Net income-137.31M

Gross profit—

Free cash flow-610.15M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNYSE

Shares out150.56M

Employees274

ListedFri, Sep 23, 2022

Free float115.28M

Float %76.6%

Short interest19M

Days to cover4.8d

Short volume46.3%

Squeeze score61 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.91 vs −$0.77

Last surprise-18.2% miss

Setup gradeD

Conviction31 / 100

Pattern quality—

Tech rank60.2 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance17.45

Support12.18

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BHVN

All disclosures →

No recent disclosed trades by Congress in BHVN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BHVN

Insider	Side	Shares	Value	Traded	Filed
Gentile Kimberly SVP, Clinical Operations · Stock Options (Right to buy) · 2026-09-15	Grant	1K	—	2026-09-15	2026-09-17

SEC filings

EDGAR filings in BHVN · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

BHVN

Recent news

Get daily signals & real-time alerts.